logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Crizotinib/lorlatinibAcquired resistance, hallucinations and slurry speech following off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2022年 / 1904卷 / 1期
关键词:
D O I:
10.1007/s40278-022-14101-z
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:169 / 169
相关论文
共 50 条
  • [21] SunitinibCardiomyopathy following off-label use: case report
    Reactions Weekly, 2023, 1971 (1) : 240 - 240
  • [22] CatequentinibPneumothorax following off-label use: case report
    Reactions Weekly, 2022, 1925 (1) : 158 - 158
  • [23] FelbamateNeutropenia following off-label use: case report
    Reactions Weekly, 2020, 1803 (1) : 111 - 111
  • [24] RituximabAgranulocytosis following off-label use: case report
    Reactions Weekly, 2018, 1712 (1) : 482 - 482
  • [25] ClonazepamMisidentification following off-label use: case report
    Reactions Weekly, 2022, 1926 (1) : 171 - 171
  • [26] SirolimusPneumonia following off-label use: case report
    Reactions Weekly, 2020, 1800 (1) : 269 - 269
  • [27] GalcanezumabConstipation following off-label use: case report
    Reactions Weekly, 2025, 2046 (1) : 169 - 169
  • [28] TolvaptanHypernatraemia following off-label use: case report
    Reactions Weekly, 2019, 1753 (1) : 326 - 326
  • [29] InsulinHypoglycaemia following off-label use: case report
    Reactions Weekly, 2021, 1843 (1) : 204 - 204
  • [30] MethylprednisoloneFungaemia following an off-label use: case report
    Reactions Weekly, 2022, 1899 (1) : 243 - 243
← 12345 →